ClaimsFiler cites Sept. 21 deadline in Primoris securities case
ClaimsFiler says Primoris Services investors seeking lead plaintiff status in a federal securities case have until Sept. 21, 2026, under an Aug. 21 notice.
ClaimsFiler said on Aug. 21 that Primoris Services Corporation investors have until Sept. 21, 2026, to seek lead plaintiff status in a securities class action in federal court in Texas.
The notice says the case is pending in the United States District Court for the Northern District of Texas. It identifies the lawsuit as Boston Retirement System v. Primoris Services Corp., No. 26-cv-02416.
What the notice says
The shareholder alert says the class period runs from Aug. 5, 2025, through June 22, 2026, inclusive.
It says the alleged issues include substantial challenges, cost overruns and project delays across six renewable energy projects. The alert also says the company’s full-year 2026 Adjusted EPS and Adjusted EBITDA guidance was overstated, along with projected 2026 renewables revenue.
ClaimsFiler said the alleged positive statements about Primoris’s business, operations and prospects were misleading or lacked a reasonable basis.
Background
Primoris trades on the New York Stock Exchange under the symbol PRIM. The ClaimsFiler notice describes the matter as a securities class action, a lawsuit brought on behalf of investors who bought shares during a stated period.
The filing says lawyers at Kahn Swick & Foti, LLC are available to discuss legal options for investors. It also provides a ClaimsFiler website and toll-free phone number for more information.
What happens next
The next stated deadline in the notice is Sept. 21, 2026, for investors seeking lead plaintiff status. The allegations remain claims in a lawsuit and have not been adjudicated.
Sources
Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.
View the Web StoryA visual, tap-through version of this reportThis is the AMP version of the article. Read the full article on Atlas Watchline.